CBPO [China Biologic Products] 8-K: (Original Filing)
[CHINA BIOLOGIC PRODUCTS, INC. AMENDED AND RESTATED DIRECTOR AGREEMENT Agreement Company Mr. David Li Director THIS AGREEMENT (this “ BACKGROUND Original Agreement The Director and the Company entered into a director agreement (the “ The Director and the Company desire to enter into this Agreement to amend and restate the Original Agreement in its entirety. AGREEMENT In consideration for the] [FOR RELEASE February 25, 2016 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015 4Q15 Total Sales Up 22.6% with Non-GAAP Net Income Up 44.5% YoY in RMB terms, or Up 17.8% YoY to $68.3 Million and 38.8% YoY to $20.4 Million in USD terms, respectively FY15 Total Sales Up 23.4% with Non-GAAP Net Income Up] []